Navigation Links
Cellular Biomedicine Group Appoints Director of Medical Research
Date:7/11/2013

PALO ALTO, Calif., July 11, 2013 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced the appointment of Maxwell Wang, M.D., PhD, as Director of Medical Research.

Dr. Wang received his MD degree from Wuerzburg University in Germany and PhD degree from University of Aberdeen, UK, following which he continued extensive research at the University of Connecticut Health Center. During his academia Dr. Wang was the first to find the paracrine and autocrine effects of CCN family genes (genes relating to connective tissue growth) in bone cell differentiation and the capability of  bone marrow-derived CTGF-GFP cells to increase bone formation. Dr. Wang is an orthopedic surgeon with over 10 years of experience in academic research focused on mesenchymal stem cells and bone cells.

Dr. Chase Dai, VP and GM of CBMG's Autologous Products Business Unit, commented, "Dr. Wang's extensive experience in the field of stem cells, particularly as applied to orthopedics, will be a valuable asset to our Knee Osteoarthritis program which is currently in clinical trial."

About Cellular Biomedicine Group
Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers.  Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards.  To learn more about CBMG, please visit: www.cellbiomedgroup
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
2. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
3. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
4. Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
5. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
6. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
7. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
8. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
9. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
10. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
11. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 21, 2014 Research and Markets  has announced ... Industry Report, 2014-2017" report to their offering. ... Chinese recombinant protein drug market has been expanding rapidly ... and the like. During 2005-2013, sales of recombinant protein ... CAGR of 19.1%, and it is projected that ...
(Date:11/21/2014)... VIENNA, Va. , Nov. 21, 2014 /PRNewswire/ ... operates in Southern California , today ... caregiving technology. Alta will be providing the innovative BeClose ... services. Logo - http://photos.prnewswire.com/prnh/20141121/160143LOGO ... to providing the kind of affordable 24/7 care our ...
(Date:11/21/2014)... Nov. 21, 2014  World Hemp Oil, an importer ... announces they are now offering legal, organic oil with ... type strains grown in medical marijuana states. People suffering ... such as Parkinson,s, MS, and spinal cord injury, no ... pass, because imported CBD Oil Is legal in all ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... ECRI Institute ®, an independent nonprofit that researches the ... of PriceGuide 4.0 , the latest generation of ... medical-surgical supplies and implants.   (Logo: ... a whole new level of interactivity and functionality for ...
... We applaud Gov. Rick Snyder for his efforts to put ... As the Governor stated, "the state of Michigan currently ... of 31.7 percent." It also has the sixth-highest rate of ... high rates of chronic conditions, Michiganders also appear to suffer ...
Cached Medicine Technology:New PriceGuide 4.0 from ECRI Institute Helps Hospitals Rein in Supply Costs 2New PriceGuide 4.0 from ECRI Institute Helps Hospitals Rein in Supply Costs 3Statement from the Michigan Society of Anesthesiologists in Response to Governor Snyder's Health & Wellness Announcement 2
(Date:11/24/2014)... Dr. Michael Kettel , a leading fertility expert ... to discuss egg freezing as a viable and increasingly accessible ... news recently, with new company benefits at Facebook and Apple ... “[The companies] see it as a way to take care ... Says Dr. Kettel. , Up until a few weeks ago, ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 24, 2014 ... Trials Review, H2, 2014" provides data on the ... information and data relating to the clinical trials ... trial numbers and their recruitment status as per ... The databook offers a preliminary coverage of disease ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous wedding ... for many products, especially the beautiful colored wedding dresses ... with amazing discounts, up to 90% off. Don’t hesitate ... easy to buy colored wedding dresses in different sizes ... famous for delicate craftsmanship, elegant style and perfect lines. ...
(Date:11/23/2014)... November 24, 2014 Tbdress.com has ... available online on Nov. 28, 2014. The special offer will ... , Tbdress.com is one of the world’s largest women’s dresses ... and colors. People can enjoy great discounts on that day: ... enjoy free delivery (for orders above $89). , People can ...
(Date:11/23/2014)... November 23, 2014 Nearly 260 ... attacks, strokes, deep vein thrombosis and other serious ... federal multidistrict litigation (MDL) underway in the Northern ... , Court documents updated on November 17th by ... show the filing of 259 lawsuits against the ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3
... French . , , Montreal, May 22, 2008 ... first trimester, according to a new study from the Universit ... edition of the British Journal of Psychiatry. , Dr. ... effect on foetal development. This is the first study to ...
... PartnerRe Ltd.,(NYSE: PRE ) today announced that ... Finance A LLC, $250 million of,10-year fixed rate 6.875% ... The Senior Notes will be fully and,unconditionally guaranteed by ... of the proceeds from the offering to,repay all of ...
... Distributor to Expand Global Reach of Novel Technology, ... Bioscience,leaders in real-time measurement of cellular bioenergetics, announced ... of Seahorse,XF instruments and consumables in Japan., ... continuing to,grow, as we have seen with the ...
... NYER ) reported results for the third quarter of ... 2008 increased $1.55,million or 8.9% to $18.92 million from $17.38 ... for the three months ended March 31, 2008,was $615,892 or ... $67,919 or $.02,per share for the same period ended March ...
... letter to Congress today about ,Breast Cancer Patient Protection ACT, ... ... WASHINGTON, May 22 "Mandatory drive-through,mastectomies is an unconscionable practice that ... Weiss, a,leading breast oncologist and Founder and President of Breastcancer.org, in,an ...
... national fats awareness campaign with ... ,Better Fats Sisters, ... "better" fats (monounsaturated and polyunsaturated) can help reduce,their risk of heart ... To view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/aha/33320/ ...
Cached Medicine News:Health News:PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes 2Health News:PartnerRe Ltd. to Issue $250 million in 6.875% Senior Notes 3Health News:Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.9 Million With Net Loss of $.16 Per Share for 3rd Quarter of Fiscal Year 2008 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.9 Million With Net Loss of $.16 Per Share for 3rd Quarter of Fiscal Year 2008 3Health News:Drive-Through Mastectomies Threaten Patients' Lives 2Health News:Video: Most Americans Don't Know 'Better Fats' Benefit Heart Health 2Health News:Video: Most Americans Don't Know 'Better Fats' Benefit Heart Health 3
For the quantitative determination of Creatine Kinase in serum....
For the qualitative determination of magnesium in serum....
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: